[go: up one dir, main page]

Follow
Rachel Golonka
Rachel Golonka
Graduate Student, University of Toledo College of Medicine and Life Sciences
Verified email at rockets.utoledo.edu
Title
Cited by
Cited by
Year
Crosstalk between gut microbiota and host immunity: impact on inflammation and immunotherapy
C Campbell, MR Kandalgaonkar, RM Golonka, BS Yeoh, M Vijay-Kumar, ...
Biomedicines 11 (2), 294, 2023
2322023
Microbiota fermentation-NLRP3 axis shapes the impact of dietary fibres on intestinal inflammation
V Singh, B San Yeoh, RE Walker, X Xiao, P Saha, RM Golonka, J Cai, ...
Gut 68 (10), 1801-1812, 2019
2182019
The iron tug-of-war between bacterial siderophores and innate immunity
R Golonka, BS Yeoh, M Vijay-Kumar
Journal of innate immunity 11 (3), 249-262, 2019
1912019
Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease
RM Golonka, P Saha, BS Yeoh, S Chattopadhyay, AT Gewirtz, B Joe, ...
Physiological genomics 52 (5), 217-221, 2020
1252020
Gnotobiotic Rats Reveal That Gut Microbiota Regulates Colonic mRNA of Ace2, the Receptor for SARS-CoV-2 Infectivity
T Yang, S Chakraborty, P Saha, B Mell, X Cheng, JY Yeo, X Mei, G Zhou, ...
Hypertension 76 (1), e1-e3, 2020
862020
PAD4-dependent NETs generation are indispensable for intestinal clearance of Citrobacter rodentium
P Saha, B San Yeoh, X Xiao, RM Golonka, V Singh, Y Wang, ...
Mucosal immunology 12 (3), 761-771, 2019
802019
Microbiota introduced to germ-free rats restores vascular contractility and blood pressure
B Joe, CG McCarthy, JM Edwards, X Cheng, S Chakraborty, T Yang, ...
Hypertension 76 (6), 1847-1855, 2020
742020
Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota
V Singh, BS Yeoh, AA Abokor, RM Golonka, Y Tian, AD Patterson, B Joe, ...
Gut Microbes 11 (4), 1077-1091, 2020
682020
Altered nutrient status reprograms host inflammation and metabolic health via gut microbiota
RM Golonka, X Xiao, AA Abokor, B Joe, M Vijay-Kumar
The Journal of nutritional biochemistry 80, 108360, 2020
552020
Enterobactin, an iron chelating bacterial siderophore, arrests cancer cell proliferation
P Saha, B San Yeoh, X Xiao, RM Golonka, S Kumarasamy, ...
Biochemical pharmacology 168, 71-81, 2019
522019
Immunoglobulin A, an active liaison for host-microbiota homeostasis
AA Abokor, GH McDaniel, RM Golonka, C Campbell, S Brahmandam, ...
Microorganisms 9 (10), 2117, 2021
492021
Innate immune cells and hypertension: neutrophils and neutrophil extracellular traps (NETs)
CG McCarthy, P Saha, RM Golonka, CF Wenceslau, B Joe, ...
Comprehensive Physiology 11 (2), 1575-1589, 2021
482021
Diurnal timing dependent alterations in gut microbial composition are synchronously linked to salt-sensitive hypertension and renal damage
S Chakraborty, J Mandal, X Cheng, S Galla, A Hindupur, P Saha, ...
Hypertension 76 (1), 59-72, 2020
442020
Deoxyribonuclease I activity, cell-free DNA, and risk of liver cancer in a prospective cohort
RM Golonka, BS Yeoh, JL Petrick, SJ Weinstein, D Albanes, AT Gewirtz, ...
JNCI cancer spectrum 2 (4), pky083, 2018
282018
Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome
RM Golonka, M Vijay-Kumar
Advances in cancer research 149, 171-255, 2021
272021
Dietary additives and supplements revisited: the fewer, the safer for gut and liver health
RM Golonka, BS Yeoh, M Vijay-Kumar
Current pharmacology reports 5 (4), 303-316, 2019
272019
Conjugated bile acids are nutritionally re-programmable antihypertensive metabolites
S Chakraborty, A Lulla, X Cheng, JY Yeo, J Mandal, T Yang, X Mei, ...
Journal of hypertension 41 (6), 979-994, 2023
252023
Enterohepatic shunt-driven cholemia predisposes to liver cancer
B San Yeoh, P Saha, RM Golonka, J Zou, JL Petrick, AA Abokor, X Xiao, ...
Gastroenterology 163 (6), 1658-1671. e16, 2022
232022
Enterobactin induces the chemokine, interleukin-8, from intestinal epithelia by chelating intracellular iron
P Saha, BS Yeoh, X Xiao, RM Golonka, AA Abokor, CF Wenceslau, ...
Gut Microbes 12 (1), 1841548, 2020
232020
Bacterial flagellin is a dominant, stable innate immune activator in the gastrointestinal contents of mice and rats
M Vijay-Kumar, VR Bovilla, BS Yeoh, RM Golonka, P Saha, B Joe, ...
Gut Microbes 15 (1), 2185031, 2023
212023
The system can't perform the operation now. Try again later.
Articles 1–20